基本信息
views: 0
Career Trajectory
Bio
Since 2006 Dr. Wellendorph has focused gradually more on the elucidation of the pharmacology and biological role of the naturally occurring compound gamma-hydroxybutyric acid (GHB) - also known as the drug of abuse Fantasy/liquid X and the narcolepsy drug Xyrem/sodium oxybate. She is now a member of the Molecular and Cellular Pharmacology discipline and the cluster for Molecular Neuroprotection. Her research group is focusing primarily on brain targets for GHB and GABA. In 2013 Dr. Wellendorph was awarded a Lundbeck Foundation Fellowship in 2013 (10M DKK) and in 2019 a follow-up thematic grant on brain mechanisms (10M DKK). Lately, activities have increasingly focused on the innovation potential of GHB analogs, supported by pre-seed funding from the Novo Nordisk Foundation in collaboration with colleagues Prof. Bente Frølund and Assoc. Prof. Birgitte Kornum (both UCPH). Petrine Wellendorph was a member of the Young Academy of Sciences at the Royal Danish Academy of Sciences and Letters (www.youngacademy.dk).
Research Interests
Papers共 125 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Basic & clinical pharmacology & toxicologyno. 6 (2024): 767-769
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGYno. 2 (2024): 203-205
Gliano. 10 (2024): 1821-1839
Expert opinion on therapeutic targetsno. 7 (2024): 529-543
biorxiv(2024)
Nane Griem-Krey,Anders B. Klein,Bettina H. Clausen,Mathias R. J. Namini,Pernille Nielsen, Mozammel Bhuiyan, Raghavendra Y. Nagaraja,T. Michael De Silva, Christopher G. Sobey,Heung-Chin Cheng,Cyrille Orset,Denis Vivien,
Journal of cerebral blood flow and metabolismno. 8 (2023): 1419-1434
Sleepno. 9 (2023)
Load More
Author Statistics
#Papers: 125
#Citation: 3140
H-Index: 29
G-Index: 53
Sociability: 6
Diversity: 3
Activity: 43
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn